U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease. It's only the second drug that ...
The FDA approved the experimental Alzheimer's drug donanemab. The drug will be sold under the brand name Kisunla.
Jake Mintz and Jordan Shusterman dig into what is going wrong with the Yankees, who was selected as an All-Star starter and ...
The agency determined that the potential of slowing the devastating disease in patients with mild cognitive impairment ...
Key Takeaways Eli Lilly received FDA approval for a drug to help treat Alzheimer's on Tuesday after studies showed it could ...
Alzheimer’s drug that can slow the disease by several months. FDA approves a second Alzheimer’s drug that can slow the ...
The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second ...
Lilly’s drug that can slow Alzheimer’s disease has received the approval of the U.S. Food and Drug Administration; the ...
It’s only the second drug that’s been convincingly shown to delay cognitive decline in patients, following last year’s ...
The FDA has approved Eli Lilly's Alzheimer's drug that can slow memory decline. CONWAY GITTENS: I’m Conway Gittens reporting ...
The U.S. Food and Drug Administration on Tuesday approved Eli Lilly’s treatment for early Alzheimer’s, making it the second ...
The FDA approved Eli Lilly's Alzheimer's drug, expanding treatment options for the disease in the US. It will be sold under ...